These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16937498)

  • 21. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
    La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F
    Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
    Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative evaluation of the omeprasol and pantoprasol efficacy in treatment of gastropathy induced by non-steroid anti-inflammatory drugs in the patients with rheumatoid arthritis].
    Zufarov PS; Iakubov AV; Salaeva DT
    Lik Sprava; 2009; (3-4):44-9. PubMed ID: 19960588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sucrose permeability as a marker for nonsteroidal anti-inflammatory gastroduodenal injury: how sweet is it?
    DeMeo M
    Nutr Rev; 1995 Jan; 53(1):13-6. PubMed ID: 7885621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive detection of nonsteroidal anti-inflammatory drug-induced gastropathy in dogs.
    Meddings JB; Kirk D; Olson ME
    Am J Vet Res; 1995 Aug; 56(8):977-81. PubMed ID: 8533987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms during proton pump inhibitor treatment: are G-protein β3 subunit genotype, Helicobacter pylori status, and environmental factors response modifiers?
    Holtmann G; van Rensburg C; Schwan T; Sander P; Siffert W
    Digestion; 2011; 84(4):289-98. PubMed ID: 22041889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter study of the safety/efficacy of misoprostol in the prevention and treatment of NSAID-induced gastroduodenal lesions.
    Grazioli I; Avossa M; Bogliolo A; Broggini M; Carcassi A; Carcassi U; Cecconami L; Ligniere GC; Colombo B; Consoli G
    Clin Exp Rheumatol; 1993; 11(3):289-94. PubMed ID: 8353983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
    Fitton A; Wiseman L
    Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative clinical trial of S-pantoprazole versus racemic pantoprazole in the treatment of gastro-esophageal reflux disease.
    Pai VG; Pai NV; Thacker HP; Shinde JK; Mandora VP; Erram SS
    World J Gastroenterol; 2006 Oct; 12(37):6017-20. PubMed ID: 17009401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients.
    Pilotto A; Leandro G; Franceschi M; Bierti L; Di Battista R; Notarbartolo A; Pisciotta G; Grassi A; Crestani B; Tafner G; Michelagnoli S; Garotta F
    Hepatogastroenterology; 1999; 46(25):245-51. PubMed ID: 10228801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of prostaglandin E2 on disease activity, gastric secretion and intestinal permeability, and morphology in patients with rheumatoid arthritis.
    Henriksson AE; Tagesson C; Uribe A; Uvnäs-Moberg K; Nord CE; Gullberg R; Johansson C
    Ann Rheum Dis; 1988 Aug; 47(8):620-7. PubMed ID: 3166369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of non-steroidal anti-inflammatory drugs on the human small intestine.
    Bjarnason I; Zanelli G; Prouse P; Williams P; Gumpel MJ; Levi AJ
    Drugs; 1986; 32 Suppl 1():35-41. PubMed ID: 3780475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrointestinal tolerability of ibuprofen administered in two pharmaceutical formulations.
    Zuin M; Podda M; Selmi C; Giorgini A; Zermiani P; Mandelli G; Sacchetta AC; Candiani C
    Arzneimittelforschung; 2000 Sep; 50(9):837-42. PubMed ID: 11050702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs.
    Sugimori S; Watanabe T; Tabuchi M; Kameda N; Machida H; Okazaki H; Tanigawa T; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Oshitani N; Koike T; Higuchi K; Arakawa T
    Digestion; 2008; 78(4):208-13. PubMed ID: 19142000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of peptic ulcer in rheumatoid arthritis.
    Tuteja AK; Malviya AN; Bannerjee S; Singh RR; Anand BS
    J Assoc Physicians India; 1991 Jul; 39(7):521-2. PubMed ID: 1800492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of pharmacokinetic interaction between pantoprazole and diclofenac.
    Bliesath H; Huber R; Steinijans VW; Koch HJ; Wurst W; Mascher H
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S76-80. PubMed ID: 8793607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of lansoprazole against peptic ulcers induced by non-steroidal anti-inflammatory drugs: endoscopic evaluation of ulcer healing.
    Matsukawa Y; Tomita Y; Nishinarita S; Horie T; Kato K; Arakawa Y; Ko K; Shimada H; Nakano M; Kitami Y; Kurosaka H
    J Int Med Res; 1997; 25(4):190-5. PubMed ID: 9283991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.